anmelden
OMX Nordic 40
2.616,23
PKT
+12,38
PKT
+0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.01.19 | Volvo (B) buy | Kepler Cheuvreux | |
| 31.01.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 31.01.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 31.01.19 | Nokia Outperform | Credit Suisse Group | |
| 31.01.19 | Nokia buy | UBS AG | |
| 30.01.19 | Volvo (B) Sell | UBS AG | |
| 30.01.19 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 29.01.19 | Nokia Outperform | Credit Suisse Group | |
| 28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.01.19 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 28.01.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 28.01.19 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.19 | Ericsson (Telefon L.M.Ericsson) (B) Equal weight | Barclays Capital | |
| 22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.01.19 | Nokia Outperform | Credit Suisse Group | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.01.19 | Nokia buy | UBS AG | |
| 17.01.19 | Nokia overweight | Barclays Capital | |
| 16.01.19 | Volvo (B) Sell | UBS AG | |
| 15.01.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 14.01.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 14.01.19 | Volvo (B) Sell | UBS AG | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.01.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.01.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 08.01.19 | ABB (Asea Brown Boveri) buy | Merrill Lynch & Co., Inc. | |
| 07.01.19 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 04.01.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 04.01.19 | Volvo (B) Sell | UBS AG | |
| 03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
| 03.01.19 | Volvo (B) Sell | UBS AG | |
| 02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 19.12.18 | Nokia Outperform | Credit Suisse Group |